l General Information |
Product Name | Nylidrin Hydrochloride |
General description | Nylidrin hydrochloride was an effective inhibitor of the IgG1-mediated release of histamine from passively sensitized guinea pig lung slices, and of the IgE-mediated release of histamine from passively sensitized rat peritoneal mast cells and human basophils. |
Synonym | Buphenine hydrochloride; 4-[1-hydroxy-2-(4-phenylbutan-2-ylamino)propyl]phenol; hydrochloride |
Purity | ≥99.0%(HPLC) | CAS Number | 849-55-8 |
Formula | C19H26ClNO2 | Molecular Weight | 335.87 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | Solid |
Solubility(25°C) | Water | ≥50mg/ml |
l Biological Information |
Biochem/Physiol
Actions | A beta-adrenergic agonist. Nylidrin causes peripheral vasodilation, a positive inotropic effect, and increased gastric volume of gastric juice. It is used in the treatment of peripheral vascular disorders and premature labor. |
l Storage |
Storage temp. | -20°C |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
